Navigation Links
Study of Drug Therapy for Compulsive Buying Yields a Puzzle,,Stanford Researcher Says

said Koran. "We're dealing with a behavior that has different biological roots in different people and therefore we may have had very different groups of people in the two studies."

In the 2003 study, 24 patients were all initially given citalopram for the open-label portion of the study, during which they all knew they were taking citalopram. Fifteen of those patients reported marked improvements in their buying behaviors. For the second portion of that trial, these 15 patients were randomly assigned to take either citalopram or a placebo without knowing which one they were taking. Of seven patients who continued taking the medication, all seven maintained their improvement, while five of the eight patients receiving a placebo relapsed.

People suffering from compulsive buying disorder are preoccupied with shopping for unneeded items and are frequently unable to resist purchasing them. The problem is not a simple lack of willpower, said Koran, who described it as being as real a disorder as other impulsive behaviors such as alcoholism and pathological gambling. Sufferers of the disorder commonly wind up with closets or rooms filled with unwanted purchases, amassing thousands of dollars of debt in the process and often damaging their relationships by lying to loved ones about their purchases.

A recent nationwide, random-sample telephone survey conducted by Koran and his colleagues indicated that compulsive buying appeared to affect nearly 6 percent of the U.S. population, with nearly equal proportions of men and women affected.

Koran said a larger double-blind, placebo-controlled clinical trial is needed to reach a conclusive result regarding the effectiveness of escitalopram in treating patients with compulsive buying disorder.

He suggested future clinical trials might be able to yield more information if they were combined with imaging studies of the patients' brains. He cited recent work by Brian Knutson, PhD, assistant professor
'"/>




Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
(Date:11/6/2009).../ -- With his proposed health care reform plan, Pr... name-brand prescription drug costs by 50 percent ...overage gap, universally known as the "donut hole....ting and feel it,s a promising start to health car...want a revised program that completely eliminates ...
(Date:11/6/2009)... -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) ...opharmaceutical company developing human vaccines ...cy Virus) and other infectious agents, today annou...provided an operational update. ,, Robert McNal...ommented, "We are pleased with our progress during...
(Date:11/5/2009)...rstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a le...r regenerative healing, today reported financial r...009. ,, "During the third quarter of 2009, our ... products MagniFuse(TM) Bone Graft, FacetLinx(TM)...rafting," said Sam Owusu-Akyaw, President and Chie...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 2GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 3GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 4GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 5GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 6GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 7GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update 8Osteotech Reports Third Quarter 2009 Financial Results 2Osteotech Reports Third Quarter 2009 Financial Results 3Osteotech Reports Third Quarter 2009 Financial Results 4Osteotech Reports Third Quarter 2009 Financial Results 5Osteotech Reports Third Quarter 2009 Financial Results 6Osteotech Reports Third Quarter 2009 Financial Results 7Osteotech Reports Third Quarter 2009 Financial Results 8Screen All Newborns for Hip Dysplasia Study Urges 51115 1Screen All Newborns for Hip Dysplasia Study Urges 51115 2Portola Pharmaceuticals to Host Conference Call at 11 3A00 a m Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update 51112 1Portola Pharmaceuticals to Host Conference Call at 11 3A00 a m Eastern Time Tomorrow to Discuss Betrixaban Partnership and Provide Corporate Update 51112 2Health clinic conditions may be to blame for decrease in primary care physicians 51108 1Health clinic conditions may be to blame for decrease in primary care physicians 51108 2
...any, February 3 Pieris AG, a,biopharmaceutical co...argeted,human protein therapeutics, reports today ...opment of its Anticalin(R) candidate PRS-050, a po...ability. , Having successfully demonstrated th...Pieris has now validated the efficacy of the Antic...
...terMune, Inc.,(Nasdaq: ITMN ) today announced th...Y program of pirfenidone in idiopathic pulmonary f...ruary 3. InterMune will conduct a conference,call..., to discuss results,from the CAPACITY program at ...3. , To access the live teleconference, dial 8...
Other Medicine Technology:Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 2Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist 3InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2
(Date:11/8/2009)...ring pain now can take you out of the game later, ...y News) -- Foot injuries are the talk of the NFL t...li Manning and running back Willie Parker. , Of...ion and American Academy of Podiatric Sports Medic...t when they play fall sports like football and lac...
(Date:11/8/2009)... 3D Global Solutions is pleas...ram managing the proposal effort for ReSound who r...igital Hearing Aid contract. The award includes no...epartment of Defense and other federal agencies. ...ember 8, 2009 -- 3D Global Solutions is pleased to...
(Date:11/8/2009)..., "One victory does not mean the battle is won," ...7 In a vote of 240-194,...nski-Smith Amendment to prohibit abortion mandates... ,, Americans United for Life Action President ...this amendment is a victory for the pro-life Ameri...
(Date:11/8/2009)..., WASHINGTON, Nov. 8 Th...irector, Operation Rescue Insurrecta Nex. ,, M...y have been fighting to keep child-killing by abor... Mr. Terry states: "This is a great first step to ... we have a lot of fighting ahead of us. Our rejoic...
(Date:11/7/2009)..., WASHINGTON, Nov. 7 Ka... Insurance Plans (AHIP), released the following st... "Health plans strongly support comprehensive heal...scussion by proposing a complete overhaul of how h... proposed guaranteed coverage, elimination of pre-...
Breaking Medicine News(10 mins):Health News:Rx for Fall Foot Injuries 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2
...tors around the United States walk a tightrope str... -- and the risk of abetting illegal and life-dest...heir medical license for doing so. , They walk t...ased the pain of millions, but have also become lu...
...hcare,REIT, Inc. today announced the promotion of ...itions. Prosky had served as Vice President of,Acq...l public offering in,September 2006., Prosky is r...s played a key role in building the existing,portf...
...ls Affiliates Nationwide, CHICAGO, April 10 As t...ople living with autism during April,s Autism Awar...eceived $350,000 in grants this,month from the CVS...are part of CVS Caremark,s signature program, CVS,...
...latform is Gaining Significant Usage ...10 GoLightly, Inc., a market,leader in delivering...se,networking and online community software soluti... become,GoLightly clients. These market leaders ha...
...undation (NOF) has partnered with CESLIE - The Wom...rak women - a dynamic mother-daughter trio -,for t...d dedication to,osteoporosis prevention. Joan Rive...nd networking event with members,of Momentum Women...
...nue Growth, Largest in Four ...ics (Nasdaq:,CDIC), the innovator and leader of Im...ed financial results for fiscal first quarter 2008... -- Record $2.3 million international sales, an in...
Other Medicine News:Health News:Study shows doctor's offices can help stem abuse of Oxycontin, other narcotic painkillers 2Health News:Study shows doctor's offices can help stem abuse of Oxycontin, other narcotic painkillers 3Health News:Study shows doctor's offices can help stem abuse of Oxycontin, other narcotic painkillers 4Health News:Grubb & Ellis Healthcare REIT Names Danny Prosky Executive Vice President, Acquisitions 2Health News:Grubb & Ellis Healthcare REIT Names Danny Prosky Executive Vice President, Acquisitions 3Health News:Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 2Health News:Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children 3Health News:Healthcare Sector Benefits from Online Community 2Health News:National Osteoporosis Foundation and CESLIE - The Women's Network Honor LeFrak Mother and Daughters for Commitment to Bone Health and New York Community 2Health News:CardioDynamics Reports 22% Revenue Growth in First Quarter 2008 2Health News:CardioDynamics Reports 22% Revenue Growth in First Quarter 2008 3Health News:CardioDynamics Reports 22% Revenue Growth in First Quarter 2008 4Health News:CardioDynamics Reports 22% Revenue Growth in First Quarter 2008 5Health News:CardioDynamics Reports 22% Revenue Growth in First Quarter 2008 6
Portable Operation Microscope
Perforated Conformer (Medium 23mm)
Endonasal Forceps
Ritleng Probe
Medicine Products: